FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498397012 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3357851001000118 Tablette de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799361000241114 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet (unit of presentation) Is a Unit of presentation (unit of presentation) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Methylphenidate hydrochloride 5 mg chewable tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Methylphenidate hydrochloride 5 mg chewable tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Miconazole nitrate 50 mg buccal tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Miconazole nitrate 50 mg buccal tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Methylphenidate hydrochloride 10 mg chewable tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Methylphenidate hydrochloride 10 mg chewable tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely clonazepam 125 microgram/1 each conventional release orodispersible tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely clonazepam 125 microgram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely donepezil hydrochloride 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely donepezil hydrochloride 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Clonazepam 250 microgram orodispersible tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Clonazepam 250 microgram orodispersible tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Donepezil hydrochloride 5 mg orodispersible tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Donepezil hydrochloride 5 mg orodispersible tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Clonazepam 500 microgram orodispersible tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Clonazepam 500 microgram orodispersible tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Clonazepam 1 mg orodispersible tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Clonazepam 1 mg orodispersible tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely iodine (as povidone iodine) 200 milligram/1 each conventional release vaginal tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely iodine (as povidone iodine) 200 milligram/1 each conventional release vaginal tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Clonazepam 2 mg orodispersible tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Clonazepam 2 mg orodispersible tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Lansoprazole 15 mg orodispersible tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Lansoprazole 15 mg orodispersible tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Lansoprazole 30 mg orodispersible tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Lansoprazole 30 mg orodispersible tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely methylphenidate hydrochloride 2.5 milligram/1 each conventional release chewable tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely methylphenidate hydrochloride 2.5 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Vardenafil (as vardenafil hydrochloride) 10 mg orodispersible tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Vardenafil (as vardenafil hydrochloride) 10 mg orodispersible tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Piroxicam 10 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Piroxicam 10 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Mycophenolic acid (as mycophenolate sodium) 360 mg gastro-resistant oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Mycophenolic acid (as mycophenolate sodium) 360 mg gastro-resistant oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Lamotrigine 200 mg orodispersible tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Lamotrigine 200 mg orodispersible tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Lamotrigine 50 mg orodispersible tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Lamotrigine 50 mg orodispersible tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely lamotrigine 5 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely lamotrigine 5 milligram/1 each conventional release chewable tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Paracetamol 650 mg and pentazocine 25 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Paracetamol 650 mg and pentazocine 25 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Paracetamol 650 mg and pentazocine 25 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely clotrimazole 100 milligram/1 each conventional release vaginal tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely clotrimazole 100 milligram/1 each conventional release vaginal tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely clotrimazole 200 milligram/1 each conventional release vaginal tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely clotrimazole 200 milligram/1 each conventional release vaginal tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely zolpidem tartrate 10 milligram/1 each conventional release sublingual tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely zolpidem tartrate 10 milligram/1 each conventional release sublingual tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely zolpidem tartrate 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely zolpidem tartrate 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely zolpidem tartrate 5 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely zolpidem tartrate 5 milligram/1 each conventional release orodispersible tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Zolpidem tartrate 5 mg sublingual tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Zolpidem tartrate 5 mg sublingual tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely valproic acid 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely valproic acid 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely valproic acid (as valproate semisodium) 125 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely valproic acid (as valproate semisodium) 125 milligram/1 each gastro-resistant oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Benserazide 12.5 mg and levodopa 50 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Benserazide 12.5 mg and levodopa 50 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Benserazide 12.5 mg and levodopa 50 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely cefaclor anhydrous (as cefaclor) 250 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely cefaclor anhydrous (as cefaclor) 250 milligram/1 each conventional release chewable tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely amoxicillin anhydrous (as amoxicillin) 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug) Has unit of presentation False Tablet (unit of presentation) Inferred relationship Some
Product containing precisely amoxicillin anhydrous (as amoxicillin) 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 3
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 3
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit (attribute) False Tablet (unit of presentation) Inferred relationship Some 1

Start Previous Page 63 of 81 Next End

This concept is not in any reference sets

Back to Start